_version_ 1784764003970449408
author Manzoni, Marco
Bosi, Alessandro
Fabris, Sonia
Lionetti, Marta
Salerio, Simone
Migliorini, Anna Chiara
Cavallaro, Francesca
Barbullushi, Kordelia
Rampi, Nicolò
Montefusco, Vittorio
Alessio, Maria Grazia
Neri, Antonino
Baldini, Luca
Sciumè, Mariarita
Tagliaferri, Elena
Fracchiolla, Nicola
Bolli, Niccolò
author_facet Manzoni, Marco
Bosi, Alessandro
Fabris, Sonia
Lionetti, Marta
Salerio, Simone
Migliorini, Anna Chiara
Cavallaro, Francesca
Barbullushi, Kordelia
Rampi, Nicolò
Montefusco, Vittorio
Alessio, Maria Grazia
Neri, Antonino
Baldini, Luca
Sciumè, Mariarita
Tagliaferri, Elena
Fracchiolla, Nicola
Bolli, Niccolò
author_sort Manzoni, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-9358783
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-93587832022-08-09 Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine Manzoni, Marco Bosi, Alessandro Fabris, Sonia Lionetti, Marta Salerio, Simone Migliorini, Anna Chiara Cavallaro, Francesca Barbullushi, Kordelia Rampi, Nicolò Montefusco, Vittorio Alessio, Maria Grazia Neri, Antonino Baldini, Luca Sciumè, Mariarita Tagliaferri, Elena Fracchiolla, Nicola Bolli, Niccolò Clin Hematol Int Correspondence Springer Netherlands 2022-05-12 /pmc/articles/PMC9358783/ /pubmed/35950209 http://dx.doi.org/10.1007/s44228-022-00002-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Manzoni, Marco
Bosi, Alessandro
Fabris, Sonia
Lionetti, Marta
Salerio, Simone
Migliorini, Anna Chiara
Cavallaro, Francesca
Barbullushi, Kordelia
Rampi, Nicolò
Montefusco, Vittorio
Alessio, Maria Grazia
Neri, Antonino
Baldini, Luca
Sciumè, Mariarita
Tagliaferri, Elena
Fracchiolla, Nicola
Bolli, Niccolò
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
title Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
title_full Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
title_fullStr Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
title_full_unstemmed Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
title_short Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
title_sort clinical, morphological and clonal progression of vexas syndrome in the context of myelodysplasia treated with azacytidine
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358783/
https://www.ncbi.nlm.nih.gov/pubmed/35950209
http://dx.doi.org/10.1007/s44228-022-00002-w
work_keys_str_mv AT manzonimarco clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT bosialessandro clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT fabrissonia clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT lionettimarta clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT saleriosimone clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT miglioriniannachiara clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT cavallarofrancesca clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT barbullushikordelia clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT rampinicolo clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT montefuscovittorio clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT alessiomariagrazia clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT neriantonino clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT baldiniluca clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT sciumemariarita clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT tagliaferrielena clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT fracchiollanicola clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine
AT bolliniccolo clinicalmorphologicalandclonalprogressionofvexassyndromeinthecontextofmyelodysplasiatreatedwithazacytidine